Price Chart

Key Stats

Net Expense Ratio Discount or Premium to NAV Total Assets Under Management 30-Day Average Daily Volume
0.93% -0.02% 803.53M 825379.0
Weighted Average Dividend Yield Turnover Ratio (Generic) 1 Year Fund Level Flows Max Drawdown (Since Inception)
0.17% 179.0% -335.26M Upgrade

Basic Info

Investment Strategy
The Fund seeks daily investment results of 300% of the performance of the S&P Biotechnology Select Industry Index. The Fund creates long positions by investing at least 80% of its assets in the securities that comprise the Index and/or financial instruments that provide leveraged and unleveraged exposure to the Index.
General
Security Type Exchange-Traded Fund
Broad Asset Class Miscellaneous
Broad Category Alternative Strategies
Global Peer Group Alternative Equity Leveraged
Peer Group Equity Leverage Funds
Global Macro Alternative Equity
US Macro Large-Cap Funds
YCharts Categorization --
YCharts Benchmark --
Prospectus Objective Equity Leverage Funds
Fund Owner Firm Name Direxion
Broad Asset Class Benchmark Index
^SPXTR 100.0%

View Basic Info
Start Trial

Performance Versus Peer Group

 
20%
15%
10%
5%
0
View Category Returns. Upgrade now.
Name
1M
3M
YTD
1Y
3Y
5Y
10Y
15Y
Total Return (Price)
--
--
--
--
--
--
--
--
Total Return (NAV)
--
--
--
--
--
--
--
--
Peer Group Rtn. (NAV)
--
--
--
--
--
--
--
--
% Rank in Peer Group (NAV)
--
--
--
--
--
--
--
--

Annual Total Returns Versus Peers

Loading chart...
Name
2018
2019
2020
2021
2022
2023
2024
YTD
-57.60%
75.51%
74.66%
-64.15%
-80.36%
-13.42%
-26.02%
84.28%
-4.38%
31.49%
18.40%
28.71%
-18.11%
26.29%
25.02%
17.51%
-13.48%
47.99%
2.12%
41.97%
-19.47%
24.35%
21.60%
22.88%
-22.64%
66.16%
-20.34%
75.37%
-32.10%
22.17%
55.71%
19.77%
-23.89%
75.26%
-17.16%
65.58%
-32.38%
32.76%
28.47%
28.07%
-48.47%
28.96%
-7.82%
-58.55%
-71.96%
-53.17%
36.00%
60.05%
As of December 14, 2025.

Asset Allocation

As of November 30, 2025.
Type % Net
Cash -47.95%
Stock 61.41%
Bond 25.97%
Convertible 0.00%
Preferred 0.00%
Other 60.56%
View Asset Allocation
Start Trial

Basic Info

Investment Strategy
The Fund seeks daily investment results of 300% of the performance of the S&P Biotechnology Select Industry Index. The Fund creates long positions by investing at least 80% of its assets in the securities that comprise the Index and/or financial instruments that provide leveraged and unleveraged exposure to the Index.
General
Security Type Exchange-Traded Fund
Broad Asset Class Miscellaneous
Broad Category Alternative Strategies
Global Peer Group Alternative Equity Leveraged
Peer Group Equity Leverage Funds
Global Macro Alternative Equity
US Macro Large-Cap Funds
YCharts Categorization --
YCharts Benchmark --
Prospectus Objective Equity Leverage Funds
Fund Owner Firm Name Direxion
Broad Asset Class Benchmark Index
^SPXTR 100.0%

View Basic Info
Start Trial

Top Portfolio Holders